China Animal Healthcare Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 2.76 Billion |
| Market Size (2029) | USD 4.43 Billion |
| CAGR (2024 - 2029) | 7.29 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
China Animal Healthcare Market Analysis
The China Veterinary Healthcare Market size is estimated at USD 2.76 billion in 2024, and is expected to reach USD 4.43 billion by 2029, growing at a CAGR of 7.29% during the forecast period (2024-2029).
The COVID-19 has also impacted the market negatively during the pandemic. For instance, according to the study published on 'Effect of COVID-19 on animal breeding development in China and its countermeasures' in 'Animal Frontiers' in February 2021, during the COVID-19 outbreak, China's agricultural production has been severely affected and a significant amount of money was required for secure isolation and employee health management, causing some businesses to break the capital chain. This has led to a lack of proper nutrition in animals, which further leads to the probability of an increase of diseases in the animals due to lack of immunity, thereby driving the market growth.
Rising public organization initiatives in China on educating people about the adoption of stray animals are expected to drive the growth of the China Veterinary Healthcare market. For instance, in June 2021, Animal rights organizations in China have opened a new welfare center to educate the public about animals and encourage the adoption of stray animals, despite the fact that there are no laws in place to protect them. This will further expected to drive the growth in order to take care of stray animals, thereby expected to boost this market. Furthermore, the rise in pet adoption, advanced technology in animal healthcare, followed by rise in number of Government initiatives and initiatives from the animal welfare organizations are expected to drive the growth of this market in the forcast period.
However, the growing trend of counterfeit prescription pharmaceuticals and the lack of skilled veterinarians are a few factors that are hampering the growth of the Chinese veterinary healthcare market.
China Animal Healthcare Market Trends
This section covers the major market trends shaping the China Veterinary Healthcare Market according to our research experts:
The Dogs and Cats Segment Dominates the China Veterinary Healthcare Market
The Chinese veterinary health products for dogs and cats are gaining positive recognition across the industry. The increased adoption of dogs and cats in China is the major driving factor for the market.
Furthermore, according to the news published in May 2020, Pet detective services are in high demand in China as the popularity of companion animals such as cats and dogs grows significantly. This will further lead to higher adoption of dog and cat veterinary healthcare services and is expected to drive the growth of this segment in China.
Moreover, technological advancements in pet health especially the dogs and cats in China is further expected to drive the growth of the segment in China. For instance, in Oct 2021, JD Health is expanding its telemedicine services to include dogs. JD Health and JD Pet had started "JD Pet Hospital," an O2O healthcare service platform that spans the entire lifespan of dogs, from disease prevention and diagnosis to comprehensive health management. The rising telehealth initiatives in veterinary health especially dogs and cats in China are further expected to drive the growth of this segment in China.
Therefore, factors such as increasing pet detective services and initiatives such as telehealth in veterinary medicine are expected to drive the growth of this segment in China.
China Animal Healthcare Industry Overview
The China veterinary healthcare market is highly competitive. Over the recent years, multinational pharmaceutical enterprises began to realize that China provides great opportunities in the animal health sector, where the emergence of new diseases among pigs, new government policies to improve food safety, and the overall development of the pig industry point toward the future growth of the country's veterinary healthcare market. The key market players operating in China veterinary healthcare market are Zoetis Inc, Vetoquinol SA, Ceva Sante Animale, Boehringer Ingelheim and Elanco among others.
China Animal Healthcare Market Leaders
-
Vetoquinol SA
-
Boehringer Ingelheim
-
Merck & Co., Inc.
-
Ceva Sante Animale
-
Elanco
*Disclaimer: Major Players sorted in no particular order
China Animal Healthcare Market News
- In May 2021, Boehringer Ingelheim has launched GastroGard(omeprazole oral paste) in the Chinese market, has been granted by the Registration Certificate of Imported Veterinary Drug by the Ministry of Agriculture and Rural Affairs of China, making it the first equine drug approved to be imported into the China market.
- In September 2020, Boehringer Ingelheim has acquired an equity stake in China-based New Ruipeng Group (NRP Group). NRP Group is a fast-growing business that offers veterinary care, e-commerce and many other services to pet owners and the broader animal health market across China.
China Animal Healthcare Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Pet Adoption
- 4.2.2 Advanced Technology in Animal Healthcare
- 4.2.3 Rise in the number of Initiatives by Governments and Animal Welfare Associations
-
4.3 Market Restraints
- 4.3.1 Use of Counterfeit Medicines
- 4.3.2 Increasing Costs of Animal Testing and Veterinary Care
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 By Therapeutics
- 5.1.1.1 Vaccines
- 5.1.1.2 Parasiticides
- 5.1.1.3 Anti-infectives
- 5.1.1.4 Medical Feed Additives
- 5.1.1.5 Other Therapeutics
- 5.1.2 By Diagnostics
- 5.1.2.1 Immunodiagnostic Tests
- 5.1.2.2 Molecular Diagnostics
- 5.1.2.3 Diagnostic Imaging
- 5.1.2.4 Clinical Chemistry
- 5.1.2.5 Other Diagnostics
-
5.2 By Animal Type
- 5.2.1 Dogs and Cats
- 5.2.2 Horses
- 5.2.3 Ruminants
- 5.2.4 Swine
- 5.2.5 Poultry
- 5.2.6 Other Animals
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Ceva Sante Animale
- 6.1.2 Boehringer Ingelheim GMBH
- 6.1.3 Elanco Animal Health Incorporated
- 6.1.4 Merck & Co., Inc.
- 6.1.5 Vetoquinol SA
- 6.1.6 Virbac Corporation
- 6.1.7 Zoetis Inc
- 6.1.8 China Animal Husbandry Co. Ltd
- 6.1.9 BioChek BV
- 6.1.10 Bayer AG
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityChina Animal Healthcare Industry Segmentation
Veterinary healthcare can be defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals. The increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. The China veterinary healthcare market is segmented by Product (Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives, and Other Therapeutics) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other Diagnostics)), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animals). The report offers the value (in USD million) for the above segments.
| By Product | By Therapeutics | Vaccines |
| Parasiticides | ||
| Anti-infectives | ||
| Medical Feed Additives | ||
| Other Therapeutics | ||
| By Product | By Diagnostics | Immunodiagnostic Tests |
| Molecular Diagnostics | ||
| Diagnostic Imaging | ||
| Clinical Chemistry | ||
| Other Diagnostics | ||
| By Animal Type | Dogs and Cats | |
| Horses | ||
| Ruminants | ||
| Swine | ||
| Poultry | ||
| Other Animals |
China Animal Healthcare Market Research FAQs
How big is the China Veterinary Healthcare Market?
The China Veterinary Healthcare Market size is expected to reach USD 2.76 billion in 2024 and grow at a CAGR of 7.29% to reach USD 4.43 billion by 2029.
What is the current China Veterinary Healthcare Market size?
In 2024, the China Veterinary Healthcare Market size is expected to reach USD 2.76 billion.
Who are the key players in China Veterinary Healthcare Market?
Vetoquinol SA, Boehringer Ingelheim, Merck & Co., Inc., Ceva Sante Animale and Elanco are the major companies operating in the China Veterinary Healthcare Market.
What years does this China Veterinary Healthcare Market cover, and what was the market size in 2023?
In 2023, the China Veterinary Healthcare Market size was estimated at USD 2.57 billion. The report covers the China Veterinary Healthcare Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Veterinary Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
China Animal Healthcare Industry Report
Statistics for the 2024 China Animal Healthcare market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Animal Healthcare analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
